NASDAQ:FUSN Fusion Pharmaceuticals (FUSN) News Today $2.60 -0.04 (-1.52%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$2.35▼$2.8150-Day Range$2.37▼$3.7552-Week Range$1.98▼$5.63Volume107,908 shsAverage Volume32,752 shsMarket Capitalization$179.40 millionP/E RatioN/ADividend YieldN/APrice Target$10.20 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives $9.50 Average Target Price from Analystsamericanbankingnews.com - October 1 at 1:22 AMOppenheimer Initiates Coverage of Fusion Pharmaceuticals (FUSN) with Outperform Recommendationmsn.com - September 30 at 2:44 PMOppenheimer Initiates Coverage on Fusion Pharmaceuticals (NASDAQ:FUSN)americanbankingnews.com - September 30 at 1:40 AMFusion Pharmaceuticals to Present at Upcoming September Investor Conferencesfinance.yahoo.com - September 5 at 8:28 PMRaymond James Maintains Fusion Pharmaceuticals (FUSN) Outperform Recommendationmsn.com - August 29 at 3:20 AM10 Oversold Penny Stocks To Buyfinance.yahoo.com - August 14 at 9:37 AMFusion Pharmaceuticals (FUSN) Gets a Buy from Truist Financialmarkets.businessinsider.com - August 13 at 11:36 PMQ3 2023 EPS Estimates for Fusion Pharmaceuticals Inc. Raised by Wedbush (NASDAQ:FUSN)marketbeat.com - August 11 at 9:21 AMFederated Hermes Inc. Buys 2,625,000 Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)marketbeat.com - August 11 at 5:51 AMFusion Pharmaceuticals Inc. to Post Q2 2024 Earnings of ($0.28) Per Share, Wedbush Forecasts (NASDAQ:FUSN)marketbeat.com - August 10 at 9:33 AMFusion Pharmaceuticals Inc. (FUSN) Reports Q2 Loss, Misses Revenue Estimatesfinance.yahoo.com - August 8 at 12:29 PMFusion Pharmaceuticals Announces Second Quarter 2023 Financial Results and Clinical Program Updatesfinance.yahoo.com - August 8 at 7:29 AMFusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Rating of "Buy" by Brokeragesmarketbeat.com - August 7 at 5:31 AMFusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Rating of "Buy" by Analystsmarketbeat.com - July 13 at 4:20 AMFusion Pharmaceuticals Inc. (NASDAQ:FUSN) Short Interest Updatemarketbeat.com - June 30 at 7:44 PMWedbush Reiterates Fusion Pharmaceuticals (FUSN) Outperform Recommendationmsn.com - June 29 at 6:19 PMOne Fusion Pharmaceuticals Insider Raised Stake By 370% In Previous Yearfinance.yahoo.com - June 29 at 1:18 PMB.Riley Financial Sticks to Their Buy Rating for Fusion Pharmaceuticals (FUSN)markets.businessinsider.com - June 29 at 8:18 AMJonesTrading Sticks to Their Buy Rating for Fusion Pharmaceuticals (FUSN)markets.businessinsider.com - June 28 at 2:46 PMFusion Pharmaceuticals to Present Interim Data from Phase 1 Trial of FPI-1434 in Patients with Solid Tumors Expressing IGF-1Rfinance.yahoo.com - June 26 at 8:33 AMRaymond James Initiates Coverage of Fusion Pharmaceuticals (FUSN) with Outperform Recommendationnasdaq.com - June 24 at 1:39 PMFusion Pharmaceuticals (NASDAQ:FUSN) Earns Outperform Rating from Analysts at Raymond Jamesmarketbeat.com - June 23 at 9:08 AMFusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Average Rating of "Buy" by Analystsmarketbeat.com - June 18 at 4:26 AMB.Riley Financial Keeps Their Buy Rating on Fusion Pharmaceuticals (FUSN)markets.businessinsider.com - June 16 at 9:06 AMFusion Pharmaceuticals to Present at the TD Cowen Radiopharmaceutical Innovation Summitfinance.yahoo.com - June 16 at 9:06 AMFusion Announces Inducementbaystreet.ca - June 7 at 2:43 PMFusion Pharmaceuticals to Present at the Jefferies Healthcare Conferencefinance.yahoo.com - May 31 at 6:49 PMThese 2 “Strong Buy” Penny Stocks Could Surge 200% (or More), Says Wedbushfinance.yahoo.com - May 31 at 1:49 PMFusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives Consensus Recommendation of "Buy" from Brokeragesmarketbeat.com - May 24 at 4:45 AMSVB Securities Sticks to Their Buy Rating for Fusion Pharmaceuticals (FUSN)markets.businessinsider.com - May 15 at 9:21 AMEquities Analysts Offer Predictions for Fusion Pharmaceuticals Inc.'s FY2027 Earnings (NASDAQ:FUSN)marketbeat.com - May 15 at 4:38 AMRecap: Fusion Pharmaceuticals Q1 Earningsmsn.com - May 12 at 8:41 AMJonesTrading Sticks to Its Buy Rating for Fusion Pharmaceuticals (FUSN)markets.businessinsider.com - May 12 at 8:41 AMFusion Pharmaceuticals First Quarter 2023 Earnings: Misses Expectationsfinance.yahoo.com - May 12 at 8:41 AMFusion Pharmaceuticals Announces First Quarter 2023 Financial Results and Clinical Program Updatesfinance.yahoo.com - May 11 at 7:36 AMFusion Pharmaceuticals Inc. (NASDAQ:FUSN) has caught the attention of institutional investors who hold a sizeable 34% stakefinance.yahoo.com - May 10 at 10:02 AMFusion Pharmaceuticals to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Dayfinance.yahoo.com - May 9 at 8:59 AMFusion Pharmaceuticals Announces Opening of Radiopharmaceutical Manufacturing Facility to Produce Targeted Alpha Therapies for Cancerfinance.yahoo.com - May 2 at 5:43 PMFUSN Fusion Pharmaceuticals Inc.seekingalpha.com - April 20 at 7:20 PMFusion Pharmaceuticals Announces Presentation of Preclinical Data Supporting FPI-2059 and Leading Targeted Alpha Therapy Platform at AACR Annual Meetingfinance.yahoo.com - April 19 at 5:53 PMQ1 2023 Earnings Forecast for Fusion Pharmaceuticals Inc. Issued By B. Riley (NASDAQ:FUSN)marketbeat.com - April 3 at 1:39 AMFusion Pharmaceuticals' (FUSN) Buy Rating Reiterated at B. Rileymarketbeat.com - March 31 at 8:36 AMFusion Pharmaceuticals Announces First Patient Dosed in Phase 1 Study of FPI-2059, a Targeted Alpha Therapy (TAT) for the Treatment of Solid Tumors Expressing NTSR1finance.yahoo.com - March 20 at 7:42 PMFusion Pharmaceuticals Earnings Perspective: Return On Capital Employedbenzinga.com - March 20 at 2:25 PMAnalysts Issue Forecasts for Fusion Pharmaceuticals Inc.'s Q1 2024 Earnings (NASDAQ:FUSN)marketbeat.com - March 20 at 2:12 AMAnalysts Offer Insights on Healthcare Companies: Fusion Pharmaceuticals (FUSN) and ATI Physical Therapy (ATIP)markets.businessinsider.com - March 17 at 10:13 AMFusion Pharmaceuticals Inc.: Fusion Pharmaceuticals Announces Fourth Quarter 2022 Financial Results and Clinical Program Updatesfinanznachrichten.de - March 16 at 12:13 PMFusion Pharmaceuticals Announces Fourth Quarter 2022 Financial Results and Clinical Program Updatesfinance.yahoo.com - March 16 at 12:13 PMFusion Pharmaceuticals Inc. (FUSN) Reports Q4 Loss, Tops Revenue Estimatesfinance.yahoo.com - March 16 at 12:13 PMShort Interest in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Declines By 66.7%marketbeat.com - March 10 at 6:53 PM Get Fusion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FUSN and its competitors with MarketBeat's FREE daily newsletter. Email Address FUSN Media Mentions By Week FUSN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FUSN News Sentiment▼0.310.70▲Average Medical News Sentiment FUSN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FUSN Articles This Week▼61▲FUSN Articles Average Week Get Fusion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FUSN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ERYTECH Pharma News Genfit News Molecular Partners News Orchard Therapeutics News Adverum Biotechnologies News X4 Pharmaceuticals News Black Diamond Therapeutics News Invivyd News Graphite Bio News Ikena Oncology News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:FUSN) was last updated on 10/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fusion Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.